CATEGORIES

© Copyright 2004; Hanoitimes - Economic and Urban Newspaper;

The tribune of Hanoi People’s Committee

Publication Permit: 29/GP-CBC

Editor - in - Chief: Nguyen Thanh Loi

Managing Editor: Ta Thu Giang

Email : thugiang@hanoitimes.vn

Head Office: 21 Huynh Thuc Khang Street, Dong Da District, Hanoi

Branch Office: 221 Tran Phu Street, Ha Dong District, Hanoi

WORDS ON THE STREET 70th anniversary of Hanoi's Liberation Day Vietnam - Asia 2023 Smart City Summit Hanoi celebrates 15 years of administrative boundary adjustment 12th Vietnam-France decentrialized cooperation conference 31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Investment / News
Japan Taisho Group increases holding in Vietnam DHG Pharmaceutical to 32%
Ngoc Mai 06:18, 2018/08/22
DHG`s largest shareholder is State Capital Investment Corporation (SCIC) with 56.6 million shares or 43.31% of the medicine maker`s charter capital.
Japan-based Taisho Pharmaceutical completed the purchase of 9.2 million shares at DHG Pharmaceutical (DHG), increasing its stake at the latter to 32% or 41.8 million shares, Taisho said in a filing to the Ho Chi Minh City Stock Exchange (HoSE).
 
Illustrative photo.
Illustrative photo.
Before the deal, the Japanese group owned over 32.6 million shares of the Vietnamese firm or a 24.94% stake.

With a public offer of VND120,000 (US$5.20) apiece, Taisho Pharmaceutical was calculated to have spent over VND1.1 trillion (US$47.25 million) to increase its holding in DHG. 

Taisho Pharmaceutical in early June spent VND85.5 billion (US$3.71 million) for 650,000 shares of DHG, raising its holding in the Vietnamese medicine producer to 24.94%. 

DHG's largest shareholder is State Capital Investment Corporation (SCIC) with 56.6 million shares or a 43.31% stake.

On July 4, DHG Pharmaceutical's foreign ownership limit was removed, as a result, the company adjusted its targets of revenue and pre-tax profit growth of at least 13% and 7%, respectively. 

At the close on August 20, DHG's share value declined for a fifth straight day, touching to VND96,000 (US$4.13) per share. The stock stayed still on August 21.

Taisho Pharmaceuticals, headquartered in Tokyo, is a leading Japanese pharmaceutical company specializing in the manufacturing of pharmaceutical products and non-prescription dietary supplements under well-known brands.
Comments
Other news
12:17, 2025/02/25
Vietnam eyes top 3 in investment environment in ASEAN next 2 years: Party Chief
A key objective is to trim off at least 30% of administrative procedures and cut both business costs and unofficial fees.
18:03, 2025/02/22
Vietnam attracts South Korean tech investment at SEMICON Korea 2025
The event provided a platform for Vietnam to showcase its semiconductor potential and reaffirm its commitment to developing high-tech industries and strengthening international cooperation.
16:46, 2025/02/20
Swedish group plans US$1 billion investment in Binh Dinh recycling plant
By creating a large number of jobs and promoting a green economy, the initiative is important in establishing Vietnam as a global hub for the circular textile sector.
10:52, 2025/02/13
Samsung plans to invest in AI, semiconductors in Vietnam
Vietnam will continue improving its investment environment and driving strategic breakthroughs in order to usher in a new era of economic development.
17:20, 2025/02/07
Vietnam's data center construction costs among the lowest in Asia Pacific
The country has a lot of potential to become one of the most important data markets in the region.
21:05, 2025/02/03
Bright prospects for FDI inflows into Vietnam in 2025
Market size, growth potential, low labor costs, and stable political and social conditions continue to be Vietnam’s selling points in attracting foreign investors.